Skip to main content

Table 3 Imaging and medications of patients regarding access to care, by race

From: Healthcare disparities in cardio oncology: patients receive same level of surveillance regardless of race at a safety net hospital

  Black
(N = 68)
White
(N = 41)
Hispanic (N = 33) Other
(N = 7)
P-value
Number of patients with additional cardiac imaging
 MUGA scan 8 3 5 0 p = 0.55
 Cardiac CT/MRI 2 3 1 0 p = 0.63
 Stress test 13 9 8 1 p = 0.89
 RHC 3 3 0 0 p = 0.42
 LHC 4 3 1 0 p = 0.78
Medication post-chemo
 Beta blocker 38 20 14 7 p = 0.12
 ACEI/ARB 43 18 12 3 p = 0.047
 Diuretic 20 13 6 1 p = 0.54
 CCB 20 6 4 2 p = 0.13
 Hydralazine 5 2 0 0 p = 0.38
 Nitrate 2 3 0 0 p = 0.33
 MRA 2 4 1 1 p = 0.28
 Antiarrhythmic 2 2 0 0 p = 0.60
 Aspirin 19 15 7 3 p = 0.43
 Statin 24 16 11 3 p = 0.94
\